In June 2021, a 53‐year‐old Armenian non‐smoker woman with a metastatic HER2+ BC was hospitalized for asthenia, anorexia, a grade 3 thrombocytopenia, a grade 2 microcytic normochromic anemia, and a severe renal failure. Here, ERBB2 is linked to breast cancer.